VERACYTE INC (VCYT) Stock News
NASDAQ:VCYT - Nasdaq - US92337F1075 - Common Stock - Currency: USD
VCYT Latest News, Press Releases and Analysis
Exploring NASDAQ:VCYT's high growth characteristics.
Why VERACYTE INC (NASDAQ:VCYT) qualifies as a high growth stock.
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million.
Veracyte Announces Third Quarter 2024 Financial Results
Veracyte to Participate in Upcoming Investor Conferences
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024
Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
A Relative Strength Rating upgrade for Tempus AI shows improving technical performance.
Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024
VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Veracyte (NASDAQ:VCYT) just reported results for the second quarter of 2024.Ver...
Veracyte Announces Second Quarter 2024 Financial Results
The 3 Best Personalized Nutrition Stocks to Buy Now
Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.
Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024
Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
Veracyte to Participate in Upcoming Investor Conferences
VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Veracyte (NASDAQ:VCYT) just reported results for the first quarter of 2024.Vera...